Joel E. Tepper, MD, the Hector MacLean Distinguished Professor of Cancer Research in the Department of Radiation Oncology wasbe one of twenty recipients of the American Society of Clinical Oncology (ASCO) 2011 Statesman Award.
The award, presented at ASCO’s Annual Meeting in early June in Chicago, IL, recognizes the extraordinary dedication of ASCO members for their voluntary efforts that benefit the Society, the specialty of oncology, and the patients served by the profession. Each year the award is given tovolunteers who have given 20 or more cumulative years of service to the Society.
Dr. Tepper shares the award with another outstanding Lineberger Comprehensive Cancer Center member, Richard M. Goldberg, MD, Distinguished Professor and Chief of the UNC Division of Hematology/Oncology, and Physician-in-Chief of the NC Cancer Hospital.
Are cancer cells are more sensitive to microbeam radiation than normal cells?
for Study in Biomedical Engineering.
In the June issue of the journal Cancer Cell.
Paper accept in Head & Neck
In comparing IMRT, Proton and conformal therapies, they conclude that IMRT is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence.
A formal public award announcement will be at the June RTOG meeting
Prestigious $2M Grand Opportunity grant for a novel micro-RT brain tumor irradiator.
Chapter spans six states.
This novel device has the potential to accelerate cancer cell biology research worldwide.
To develop carbon nanotube micro-RT technology for use in miniature CT scanners.
Chaney invented and developed many of our current treatment planning systems
A project to improve supportive care services for younger women with breast cancer has received a grant of more than $780,000 from the Centers for Disease Control and Prevention.
Enthusiasm, performance and service are an inspiration to others.